If you have been reading about actin binding and want a single page that covers the useful parts, this is it: definitions, context, how it is studied, and the questions that come up repeatedly.
Last reviewed on 2026-01-27. Where a claim depends on a specific study, the study is described rather than over-claimed.
Published work involving this sequence spans actin-binding assays, cell-migration studies, wound-healing models, and cardiovascular or musculoskeletal experiments. Much of the biological rationale derives from in vitro systems and animal models, and the number of controlled human studies is small. Reported outcomes vary across preparations, doses, and routes, which complicates comparison between studies. Reviews generally describe the evidence base as preliminary rather than settled. Mechanistic explanations are often proposed by analogy to the parent protein rather than demonstrated directly.
TB-500 is a synthetic seven-amino-acid peptide with the sequence LKKTETQ, corresponding to residues 17 through 23 of the protein thymosin beta-4. The N-terminus is typically acetylated in the described form, giving a monoisotopic mass near 888.5 Da and an average mass of about 889 Da. The designation TB-500 is a catalogue label rather than a formal chemical name, and the same sequence appears in the literature under several alternative abbreviations. It is handled as a research reagent rather than a pharmaceutical product.
Thymosin beta-4 is a 43-residue actin-binding protein found in most mammalian cell types, where it participates in cytoskeletal regulation and cell migration. TB-500 represents only a short fragment of that protein and does not include the remaining residues. Whether the isolated fragment reproduces the full range of activities reported for the intact protein remains an open question. Researchers commonly treat the two as related but distinct entities when comparing results.
The most frequently cited identity is a seven-residue fragment with the sequence LKKTETQ, taken from the actin-binding domain of the parent protein. A separate molecule, N-acetyl-seryl-aspartyl-lysyl-proline, often shortened to Ac-SDKP, derives from the same protein's N-terminal region and appears in overlapping literature. Reported molecular masses therefore differ between sources, and a mass value on its own does not establish which fragment is present. Confirmation requires a defined sequence rather than a single number.
Research interest in thymosin beta-4 fragments centres on actin sequestration, cell migration and tissue repair models. Most published work uses cultured cells or animal wound and cardiac preparations, and findings are generally described as preliminary. No fragment of this protein has been approved as a therapeutic product by major regulators. Reviews of the field note inconsistent dosing, delivery routes and outcome measures across studies, which complicates direct comparison. The material is best understood as a laboratory reagent with an active but unresolved research literature.
| Property | Value | Notes |
|---|---|---|
| Molecular formula | C38H68N10O14 | Acetylated heptapeptide form |
| Monoisotopic mass | 888.5 Da | Average mass about 889 Da |
| Appearance | White to off-white solid | Usually supplied as lyophilised powder |
| Solubility class | Highly water soluble | Also dissolves in aqueous buffers |
| Common synonyms | Tbeta4 fragment, thymosin beta-4 (17-23) | Refer to the same sequence |
Sports authorities classify the peptide as a prohibited substance, and it appears on the World Anti-Doping Agency list under peptide hormones, growth factors, and related substances. Racing jurisdictions for horses and dogs have issued separate restrictions, and several national bodies treat it as a controlled or prescription-only item. As a research chemical it is sold without a therapeutic indication, and labels usually state that the product is not for human or veterinary use. Regulatory treatment therefore varies by country.
Detection in biological matrices generally relies on liquid chromatography coupled with tandem mass spectrometry, because the peptide lacks a convenient ultraviolet chromophore beyond the amide backbone. Immunoassays have been described, but antibodies raised against the fragment can cross-react with the full-length protein or with unrelated peptides, so findings usually require confirmation by a second technique. Sample preparation typically involves protein precipitation followed by solid-phase extraction. Reported detection windows depend on dose, route, matrix, and instrument sensitivity.
Controlled human trials of the short fragment are scarce. Much of what appears in review articles is extrapolated from animal models or from studies of the parent protein, and literature searches return a larger body of cardiac and ophthalmic work on thymosin beta-4 than on the abbreviated peptide. Regulatory treatment differs by jurisdiction, and in several countries the material is handled as a research chemical rather than an approved therapeutic. Statements about human benefit should be read as provisional.
Biological interest in this peptide centers on its relationship to actin dynamics. Thymosin beta-4 binds monomeric actin through an LKKTET motif, and a short sequence carrying that motif can compete with other actin-binding proteins in cell-free preparations. Investigators propose that such competition shifts the balance between filament assembly and disassembly, which in turn affects how readily a cell extends protrusions and migrates. Most of the supporting observations come from cultured cells and purified protein systems rather than from intact organisms.
24296Cm + 42He → 24598Cf + 10n Only about 5,000 atoms of californium were produced in this experiment. The odd-mass curium isotopes 243Cm, 245Cm, and 247Cm are all highly fissile and can release additional energy in a thermal spectrum nuclear reactor. All curium isotopes are fissionable in fast-neutron reactors. This is one of the motives for minor actinide separation and transmutation in the nuclear fuel cycle, helping to reduce the long-term radiotoxicity of used, or spent nuclear fuel.
=== Gene therapy === Viral gene therapy involves artificially manipulating a virus to include a desirable piece of genetic material. Viral gene therapies using engineered plant viruses have been proposed to enhance crop performance and promote sustainable production.
Cofran, Hurst & Hawks (2026) present a virtual reconstruction of the brain endocast of Homo naledi, providing evidence of presence of a combination of ancestral and derived features in the brain of the studied hominin. Madupe et al. (2026) determine the sex of at least 20 individuals of Homo naledi from the Rising Star cave system (Cradle of Humankind, South Africa) on the basis of proteomic analysis of tooth enamel, finding no evidence of male markers in the studied sample. Delagnes et al. (2026) study the mobility of Early Pleistocene hominins from the Lower Omo Valley (Shungura Formation, Ethiopia), providing evidence of transport of quartz for the production of Oldowan stone tools from the alluvial fans of the Hamar Range, over 10 km from the sites preserving the stone tools, located in areas that lacked stone material but had rich faunal assemblages. Evidence from the study of Oldowan tools from the Shungura Formation, indicating that different sediment types produced characteristic wear of the studied tools that can be distinguished wear caused by other types of sediment and from anthropogenic use-wear, is presented by Galland et al. (2026). Dominguez-Rodrigo et al.
==== Transformation of kerogen into fossil fuels ==== Kerogen formation continued to a depth of about 1 km from the Earth's surface where temperatures may reach around 50 °C. Kerogen formation represents a halfway point between organic matter and fossil fuels: kerogen can be exposed to oxygen, oxidize and thus be lost, or it could be buried deeper inside the Earth's crust and be subjected to conditions which allow it to slowly transform into fossil fuels like petroleum. The latter happened through catagenesis in which the reactions were mostly radical rearrangements of kerogen. These reactions took thousands to millions of years, and no external reactants were involved. Due to the radical nature of these reactions, kerogen reacted towards two classes of products: those with low H/C ratio (anthracene or products similar to it) and those with high H/C ratio (methane or products similar to it); i.e., carbon-rich or hydrogen-rich products. Because catagenesis was closed off from external reactants, the resulting composition of the fuel mixture was dependent on the composition of the kerogen via reaction stoichiometry. Three types of kerogen exist: type I (algal), II (liptinic) and III (humic), which were formed mainly from algae, plankton and woody plants (this term includes trees, shrubs and lianas) respectively.
Sources: en.wikipedia.org
TVLine reported in late April that a new gladiator would be added to Olivia Pope & Associates, and the person would be a guest star. It was also announced on July 7, 2015, that Cornelius Smith Jr., who had a guest role in season four playing activist Marcus Walker, will be returning as a series regular for the fifth season, but will not appear until later in the fall. On August 24, 2015, it was announced that actress Mia Maestro would be recurring during the fifth season, but the specifics of her role were not revealed. Julie Claire was announced on September 1, 2015, to have joined the cast in a guest role. It was announced on February 4, 2016, that Ricardo Chavira would join the show in a recurring role, and would first appear in the eleventh episode. Annabeth Gish was announced on February 8, 2016, to have been cast in a recurring role. The Hollywood Reporter announced on February 18, 2016, that Joe Morton who plays Rowan "Eli" Pope had been promoted to a series regular, and was credited as a regular cast member for the first time in the twelfth episode.
Sports tournaments in Jammu and Kashmir are organised by both the Indian army and police, as well as mainstream political parties and the All Parties Hurriyat Conference. Sportspersons who represent India in tournaments face stigmatisation from separatists. Jammu and Kashmir has 18 stadiums, 23 training centres, three indoor sports complexes and 42 government-maintained playing fields. Srinagar is home to the Sher-i-Kashmir Stadium, a stadium where international cricket matches have been played. The Maulana Azad Stadium in Jammu is one of the home venues for the Jammu and Kashmir cricket team. The Bakshi Stadium in Srinagar, named after Bakshi Ghulam Mohammad, hosts football matches. Institutions such as the Jawahar Institute of Mountaineering and Winter Sports provides mountaineering, skiing and adventure courses. The Royal Springs Golf Course, Srinagar, located on the banks of Dal lake, is considered one of the best golf courses in India. Jammu and Kashmir was also host to the first Khelo India Winter Games, held in 2020 in Gulmarg. Jammu and Kashmir came first with the most gold medals at 26, followed by the Indian Army team with 8 gold medals. The second edition of the winter games were also held in Gulmarg in 2021, with Jammu and Kashmir coming first again.
== Uses == Industrially, anthranilic acid is an intermediate in the production of azo dyes (c.f. methyl red) and saccharin. It and its esters are used in preparing perfumes to mimic jasmine and orange, pharmaceuticals (loop diuretics, such as furosemide) and UV-absorber as well as corrosion inhibitors for metals and mold inhibitors in soy sauce. Anthranilate-based insect repellents have been proposed as replacements for DEET. Fenamic acid is a derivative of anthranilic acid, which in turn is a nitrogen isostere of salicylic acid, which is the active metabolite of aspirin. Several non-steroidal anti-inflammatory drugs, including mefenamic acid, tolfenamic acid, flufenamic acid, and meclofenamic acid are derived from fenamic acid or anthranilic acid and are called "anthranilic acid derivatives" or "fenamates". Anthranilic acid [118-92-3] was demonstrated to have utility in the synthesis of the following list of substances: clozapine, quetiapine, thiosalicylic acid, ofornine, strinoline, ciliobrevin A, bentazon, quinezamide, nifurquinazol, nitromethaqualone, & YT-1 (1-azaflavone) [14802-18-7], atolide (actually isatoic anhydride), melicopicine. & tranilast. U-17660 [13450-72-1] & THA-Q [4425-23-4].
Cocaine is known to suppress hunger and appetite by increasing co-localization of sigma σ1R receptors and ghrelin GHS-R1a cell surface receptors, thereby increasing ghrelin-mediated signaling of satiety and possibly via other effects on appetitive hormones. Cocaine effects, further, are shown to be potentiated for the user when used in conjunction with new surroundings and stimuli, and otherwise novel environs.
=== Software packages === As described by Andreotti et al. in 2012, Antilope is a combination of Lagrangian relaxation and an adaptation of Yen's k shortest paths. It is based on 'spectrum graph' method and contains different scoring functions, and can be comparable on the running time and accuracy to "the popular state-of-the-art programs" PepNovo and NovoHMM. Grossmann et al. presented AUDENS in 2005 as an automated de novo peptide sequencing tool containing a preprocessing module that can recognize signal peaks and noise peaks. Lutefisk can solve de novo sequencing from CID mass spectra. In this algorithm, significant ions are first found, then determine the N- and C-terminal evidence list. Based on the sequence list, it generates complete sequences in spectra and scores them with the experimental spectrum. However, the result may include several sequence candidates that have only little difference, so it is hard to find the right peptide sequence. A second program, CIDentify, which is a modified version by Alex Taylor of Bill Pearson's FASTA algorithm, can be applied to distinguish those uncertain similar candidates. Mo et al. presented the MSNovo algorithm in 2007 and proved that it performed "better than existing de novo tools on multiple data sets". This algorithm can do de novo sequencing interpretation of LCQ, LTQ mass spectrometers and of singly, doubly, triply charged ions. Different from other algorithms, it applied a novel scoring function and use a mass array instead of a spectrum graph. Fisher et al. proposed the NovoHMM method of de novo sequencing.
Sources: en.wikipedia.org
No. TB-500 is a short synthetic peptide matching residues 17 to 23 of thymosin beta-4, while the parent protein contains 43 residues. The fragment lacks the rest of the protein sequence, so the two are related but not identical.
It consists of leucine, lysine, lysine, threonine, glutamic acid, threonine, and glutamine in that order. The N-terminal leucine is usually acetylated in the forms described in catalogues.
Controlled human data is limited, and most published findings come from cell culture or animal work. This makes it difficult to state clinical effects with confidence.
TB-500 is a trade-style label for a synthetic peptide connected to thymosin beta-4. It is sold mainly through research-chemical channels and is not a single chemically defined product across suppliers.